CompaniesAquarius Biotechnologies

Aquarius Biotechnologies

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

80

By Phase

NA: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
2029
Today
NCT06529835
Hover over trial bars to see details

Recent Trials

NCT06529835Lead Sponsor
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
NARecruiting
80 participants
Started: Mar 21, 2025 · Completed: Aug 31, 2028
Funding History (1)
D
Oct 10, 2013
Filing
Related Companies
Matinas Biopharma
acquired